Skip to Content
Merck
All Photos(1)

Documents

X0075000

Xylazine hydrochloride

European Pharmacopoeia (EP) Reference Standard

Synonym(s):

2-(2,6-Dimethylphenylamino)-5,6-dihydro-4H-thiazine hydrochloride, 5,6-Dihydro-2-(2,6-xylidino)-4H-1,3-thiazine hydrochloride

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C12H16N2S · HCl
CAS Number:
23076-35-9
Molecular Weight:
256.79
Beilstein:
6448471
MDL number:
MFCD00058196
UNSPSC Code:
41116107
PubChem Substance ID:
329830765
NACRES:
NA.24

grade

pharmaceutical primary standard

API family

xylazine

manufacturer/tradename

EDQM

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

SMILES string

Cl[H].Cc1cccc(C)c1NC2=NCCCS2

InChI

1S/C12H16N2S.ClH/c1-9-5-3-6-10(2)11(9)14-12-13-7-4-8-15-12;/h3,5-6H,4,7-8H2,1-2H3,(H,13,14);1H

InChI key

QYEFBJRXKKSABU-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Xylazine hydrochloride EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Biochem/physiol Actions

α2-Adrenergic receptor agonist, sedative, muscle relaxant.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

Pictograms

Skull and crossbones
GHS06

Signal Word

Danger

Hazard Statements

H301,H315,H319,H335

Hazard Classifications

Acute Tox. 3 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Target Organs

Respiratory system

Storage Class Code

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Ori Furman et al.
Theriogenology, 82(8), 1165-1172 (2014-09-13)
This study establishes an experimental model for subclinical mastitis induced by Gram-positive (G+) exosecretions of Staphylococcus aureus origin or Gram-negative (G-) endotoxin of Escherichia coli origin to examine its effects on follicular growth and steroid concentrations in Holstein dairy cows.
N Pluchino et al.
Steroids, 95, 104-110 (2015-01-18)
Estetrol (E4), a naturally occurring estrogen produced exclusively by human fetal liver, is currently being evaluated for potential use in contraception and menopausal care in humans. The present study was designed to profile E4 effects on the central nervous system
Marzia Ferretti et al.
Histology and histopathology, 29(8), 1027-1037 (2014-02-11)
The present paper completes our recent study on the effects of phytoestrogen ferutinin in preventing osteoporosis and demonstrating the superior osteoprotective effect of a 2 mg/kg/day dose in ovariectomized (OVX) rats, compared to both estrogens and lower (0.5, 1 mg/kg/day)
Burak Turgut et al.
Clinical & experimental ophthalmology, 43(1), 67-76 (2014-05-08)
To investigate the effects of subconjunctivally administered trastuzumab on wound healing in experimental glaucoma filtration surgery. Comparative, experimental study. Twenty eight eyes. Twenty-eight male New Zealand white rabbits were randomly assigned to four groups, each including seven rabbits: The rabbits
Javier Gutiérrez-Cuesta et al.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 39(13), 2974-2988 (2014-06-20)
The repeated cycles of cessation of consumption and relapse remain the major clinical concern in treating drug addiction. The endogenous opioid system is a crucial component of the reward circuit that participates in the adaptive changes leading to relapse in
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service